International Diabetes Federation Releases Diabetes Atlas 11th Edition (2025): Top 10 Key Takeaways from India Dr. Garima Soni11 April 2025 12:15 PM ISTDiabetes has emerged as one of the most pressing public health concerns in India. As per the International Diabetes Federation (IDF) Diabetes Atlas...
Elective Peri-Operative Management of Patients on GLP-1, GIP Agonists & SGLT-2 Inhibitors: Multidisciplinary Consensus Released Nidhi Srivastava11 Feb 2025 11:34 AM ISTUK: A recent consensus statement from leading UK medical organizations-including the Association of Anaesthetists,the Association of British Clinical...
New Dietary Recommendation for Managing Gastrointestinal Issues Treated with GLP-1 Receptor Agonists Dr Jeegar Dattani1 Feb 2025 4:51 PM ISTA recent commentary article published in Diabetes, Metabolic Syndrome and Obesity provides dietary recommendations for individuals using GLP-1...
Combination therapy with ARBs and Beta-blockers for post-PCI patients with hypertension-Expert Opinion of Indian Cardiologists Dr Jeegar Dattani4 Jun 2024 11:00 AM ISTThe expert opinion is the first of its kind, guiding Indian Cardiologists in managing hypertension in post-PCI patients with comorbidities. A total of...
Applicability of FDC of Linagliptin and Dapagliflozin in T2DM: EVERGREEN Case Report Summaries Dr Jeegar Dattani24 May 2024 11:00 AM ISTThe EVERGREEN webinar, designed to guide physicians regarding the care of people with diabetes, highlighted the clinical applicability of a...
EVERGREEN Webinar: Clinical FAQs on T2DM Care, Addressed by Dr V Mohan Dr Jeegar Dattani6 March 2024 12:29 PM ISTThe Evergreen webinar addressed the clinical applicability of Linagliptin and Dapagliflozin in real-world clinical scenarios of type 2 diabetes....
Top 10 Messages from Evergreen Webinar on Clinical Applicability of Linagliptin Dapagliflozin in Type 2 Diabetes, Addressed by Dr V Mohan Dr Jeegar Dattani12 Feb 2024 12:15 PM ISTDr. V. Mohan, M.D., FRCP (London, Edinburgh, Glasgow & Ireland), Ph.D., D.Sc. D.Sc (Hon. Causa), FNASc, FASc, FNA, FACE, FACP, FTWAS, MACP, FRSE....
Top Ten US-FDA Approved Pharmacological Agents in 2023: A Year in Review MDTV Bureau30 Dec 2023 3:51 PM ISTWe come to the end of 2023. Here are top ten pharmacological agents that received US-FDA approval throughout this year, across key therapy areas:1)...
Potassium-Competitive Acid Blockers (P- CABs) for GERD Management - Potential Game Changer or Washout? Dr Jeegar Dattani7 Dec 2023 11:30 AM ISTProton pump Inhibitors have been used globally for the management of gastroesophageal disease (GERD) and Acid Peptic Disease (APD) for a long time....
Lifestyle Interventions in Hypertension: International Society of Hypertension 2023 Position Paper Dr Jeegar Dattani17 Oct 2023 5:52 PM ISTHypertension, defined as persistently elevated systolic blood pressure (SBP) >140mmHg and/or diastolic blood pressure (DBP) at least 90mmHg...
The Doctor of the Future- How will the Roles Evolve in a Changing World? Dr Jeegar Dattani9 Sept 2023 5:15 PM ISTThe reformations in healthcare are accelerating across the globe. Healthcare is on the path to a massive transition from focusing on illness towards...
Can ChatGPT write health and medical content? Dr Jeegar Dattani31 Jan 2023 1:28 PM ISTGPT-3 (Generative Pretrained Transformer 3) is a state-of-the-art language processing AI model developed by OpenAI. It is capable of generating...
